David Markovitz, MD
University of Michigan
Dr. Markovitz is studying the role of the DEK protein in inflammation to explore possible new treatments for inflammatory arthritis, specifically juvenile idiopathic arthritis (JIA). Past research has discovered a new approach to targeting DEK as a means for reducing some forms of inflammation. Dr. Markovitz's study seeks to better understand the molecular mechanisms involved with this process, so that they may be used to one day treat children like Lilly.